Zimmer Biomet Holdings (ZBH) Change in Accured Expenses (2009 - 2026)

Zimmer Biomet Holdings has reported Change in Accured Expenses for 18 years, with the latest figure at $92.0 million in Q2 2026.

• On a quarterly basis, Change in Accured Expenses rose 19.79% year-over-year to $92.0 million in Q2 2026; TTM through Jun 2026 was -$29.6 million, a 70.43% increase from a year earlier, with the FY2025 full-year figure at $101.8 million, up 131.61% from the prior year.
• Change in Accured Expenses was $92.0 million for Q2 2026 at Zimmer Biomet Holdings, up from -$183.0 million in the prior quarter.
• The five-year high for Change in Accured Expenses was $164.2 million in Q4 2023, with the low at -$183.0 million in Q1 2026.
• Average Change in Accured Expenses over 5 years is -$14.6 million, with a median of -$34.2 million recorded in 2022.
• The sharpest annual moves came in 2023 and 2025: Change in Accured Expenses sank 477.36% in 2023, then jumped 223.67% in 2025.
• Over 5 years, Change in Accured Expenses stood at $104.6 million in 2022, then jumped by 56.98% to $164.2 million in 2023, then sank by 171.44% to -$117.3 million in 2024, then surged by 196.25% to $112.9 million in 2025, then decreased by 18.51% to $92.0 million in 2026.
• The last three Change in Accured Expenses figures came in at $92.0 million (Q2 2026), -$183.0 million (Q1 2026), and $112.9 million (Q4 2025), per Business Quant data.